This is the authors' abstract. We don't add key points for this paper.
Characterize the hepatic safety profile of troriluzole from an extensive clinical program across a diverse range of disorders.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Qureshi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: